600 related articles for article (PubMed ID: 9464617)
1. Acquired resistance to the anti-proliferative effect of interleukin-1 and interleukin-6 is a recessive phenotype in A375 human melanoma cells.
Itoh S; Hayashi H; Yang D; Takii T; Onozaki K
Melanoma Res; 1997 Dec; 7(6):455-62. PubMed ID: 9464617
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 1 (IL-1) production is not essential for acquired resistance of human A375 melanoma cells to anti-proliferative effect of IL-1.
Itoh S; Hayashi H; Watanabe N; Kobayashi Y; Takii T; Onozaki K
Int J Cancer; 1996 Mar; 65(6):805-11. PubMed ID: 8631596
[TBL] [Abstract][Full Text] [Related]
3. Resistance to the anti-proliferative effect of IL-1 on human melanoma cell line is associated with endogenous production of IL-1 and IL-6.
Araki M; Yano T; Hayashi H; Takii T; Suzuki K; Onozaki K
Int J Cancer; 1994 Jan; 56(2):275-80. PubMed ID: 8314311
[TBL] [Abstract][Full Text] [Related]
4. Resistance to IL-1 anti-proliferative effect, accompanied by characteristics of advanced melanoma, permits invasion of human melanoma cells in vitro, but not metastasis in the nude mouse.
Hayashi H; Shimizu R; Fujii K; Itoh S; Yang D; Onozaki K
Int J Cancer; 1997 May; 71(3):416-21. PubMed ID: 9139878
[TBL] [Abstract][Full Text] [Related]
5. Transfection of human melanoma cells with type I interleukin-1 (IL-1) receptor cDNA rendered them IL-1-responsive and revealed the importance of ODC activity down-regulation in IL-1-induced growth inhibition.
Yang D; Hayashi H; Hiyama Y; Takii T; Onozaki K
J Biochem; 1995 Oct; 118(4):802-9. PubMed ID: 8576096
[TBL] [Abstract][Full Text] [Related]
6. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines.
Morinaga Y; Suzuki H; Takatsuki F; Akiyama Y; Taniyama T; Matsushima K; Onozaki K
J Immunol; 1989 Dec; 143(11):3538-42. PubMed ID: 2584706
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of constitutive IL-1alpha gene expression in human melanoma cells: autocrine stimulation through NF-kappaB activation by endogenous IL-1alpha.
Kimura H; Inukai Y; Takii T; Furutani Y; Shibata Y; Hayashi H; Sakurada S; Okamoto T; Inoue J; Oomoto Y; Onozaki K
Cytokine; 1998 Nov; 10(11):872-9. PubMed ID: 9878124
[TBL] [Abstract][Full Text] [Related]
8. Differential cytostatic activity of monocyte-derived cytokines against human melanoma cells.
te Velde AA; vd Wiel-v Kemenade E; Figdor CG
Int J Cancer; 1992 Mar; 50(5):746-51. PubMed ID: 1544709
[TBL] [Abstract][Full Text] [Related]
9. MSH receptors and the response of human A375 melanoma cells to interleukin-1 beta.
Baumann JB; Bagutti C; Siegrist W; Christen E; Zumsteg U; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):199-210. PubMed ID: 9029491
[TBL] [Abstract][Full Text] [Related]
10. Activation of two distinct anti-proliferative pathways, apoptosis and p38 MAP kinase-dependent cell cycle arrest, by tumor necrosis factor in human melanoma cell line A375.
Hattori T; Hayashi H; Chiba T; Onozaki K
Eur Cytokine Netw; 2001; 12(2):244-52. PubMed ID: 11399512
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
Huang S; Xie K; Bucana CD; Ullrich SE; Bar-Eli M
Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
[TBL] [Abstract][Full Text] [Related]
12. In vitro modulation of cisplatin resistance by cytokines.
Poppenborg H; Knüpfer MM; Galla HJ; Wolff JE
Cytokine; 1999 Sep; 11(9):689-95. PubMed ID: 10479405
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375.
Itoh S; Hattori T; Hayashi H; Mizutani Y; Todo M; Takii T; Yang D; Lee JC; Matsufuji S; Murakami Y; Chiba T; Onozaki K
J Immunol; 1999 Jun; 162(12):7434-40. PubMed ID: 10358197
[TBL] [Abstract][Full Text] [Related]
14. Selection and characterization of a variant of human melanoma cell line, A375 resistant to growth inhibitory effects of oncostatin M (OM): coresistant to interleukin 6 (IL-6).
McDonald VL; Dick KO; Malik N; Shoyab M
Growth Factors; 1993; 9(3):167-75. PubMed ID: 8274294
[TBL] [Abstract][Full Text] [Related]
15. A role for the interleukin 1 receptor in the synergistic antitumor effects of human interleukin 1 alpha and etoposide against human melanoma cells.
Usui N; Mimnaugh EG; Sinha BK
Cancer Res; 1991 Feb; 51(3):769-74. PubMed ID: 1824825
[TBL] [Abstract][Full Text] [Related]
16. The interaction with Sp1 and reduction in the activity of histone deacetylase 1 are critical for the constitutive gene expression of IL-1 alpha in human melanoma cells.
Enya K; Hayashi H; Takii T; Ohoka N; Kanata S; Okamoto T; Onozaki K
J Leukoc Biol; 2008 Jan; 83(1):190-9. PubMed ID: 17906119
[TBL] [Abstract][Full Text] [Related]
17. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin M.
Silvani A; Ferrari G; Paonessa G; Toniatti C; Parmiani G; Colombo MP
Cancer Res; 1995 May; 55(10):2200-5. PubMed ID: 7743524
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
Kortylewski M; Heinrich PC; Mackiewicz A; Schniertshauer U; Klingmüller U; Nakajima K; Hirano T; Horn F; Behrmann I
Oncogene; 1999 Jun; 18(25):3742-53. PubMed ID: 10391682
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 production by human melanoma cell lines.
Lee JD; Sievers TM; Skotzko M; Chandler CF; Morton DL; McBride WH; Economou JS
Lymphokine Cytokine Res; 1992 Jun; 11(3):161-6. PubMed ID: 1391235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
